KLDO (Kaleido Biosciences) Total Liabilities: $39.53 Mil (As of Dec. 2021)


What is Kaleido Biosciences Total Liabilities?

Kaleido Biosciences KLDO -99.00% Total Liabilities is $39.53 Mil as of Dec. 2021.

Kaleido Biosciences's Total Liabilities for the quarter that ended in Dec. 2021 was $39.53 Mil.

Kaleido Biosciences's quarterly Total Liabilities increased from Jun. 2021 ($34.02 Mil) to Sep. 2021 ($38.60 Mil) and increased from Sep. 2021 ($38.60 Mil) to Dec. 2021 ($39.53 Mil).

Kaleido Biosciences's annual Total Liabilities increased from Dec. 2019 ($33.42 Mil) to Dec. 2020 ($38.85 Mil) and increased from Dec. 2020 ($38.85 Mil) to Dec. 2021 ($39.53 Mil).

Kaleido Biosciences Total Liabilities Historical Data

* Premium members only.

The historical data trend for Kaleido Biosciences's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kaleido Biosciences Total Liabilities Chart

Kaleido Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Total Liabilities
Get a 7-Day Free Trial 74.43 181.57 33.42 38.85 39.53

Kaleido Biosciences Quarterly Data
Dec16 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.85 33.25 34.02 38.60 39.53

Kaleido Biosciences Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Kaleido Biosciences's Total Liabilities for the fiscal year that ended in Dec. 2021 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=29.682+(5.55+4.298
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=39.53

Total Liabilities=Total Assets (A: Dec. 2021 )-Total Equity (A: Dec. 2021 )
=50.137-10.607
=39.53

Kaleido Biosciences's Total Liabilities for the quarter that ended in Dec. 2021 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=29.682+(5.55+4.298
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=39.53

Total Liabilities=Total Assets (Q: Dec. 2021 )-Total Equity (Q: Dec. 2021 )
=50.137-10.607
=39.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $39.53 Mil mean?
Kaleido Biosciences (KLDO) has a Total Liabilities of $39.53 Mil as of Dec. 2021. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Kaleido Biosciences and its competitors.
Is Kaleido Biosciences' Total Liabilities too high?
Kaleido Biosciences' current Total Liabilities is $39.53 Mil.
How does Kaleido Biosciences' Total Liabilities compare to NPTX and GSTC?
Kaleido Biosciences' Total Liabilities of $39.53 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Kaleido Biosciences and its competitors. Kaleido Biosciences's current Total Liabilities is $39.53 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kaleido Biosciences stock overvalued right now?
Kaleido Biosciences (KLDO) has a current Total Liabilities of $39.53 Mil. The current Total Liabilities is $39.53 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Kaleido Biosciences (KLDO), the current Total Liabilities is $39.53 Mil as of Dec. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kaleido Biosciences Business Description

Address 65 Hayden Avenue, Lexington, MA, USA, 02421
Kaleido Biosciences Inc is a clinical-stage healthcare company. It is focused on leveraging the potential of the microbiome organ to treat disease and improve human health. Its product candidates are Microbiome Metabolic Therapies, or MMTs, which are designed to modulate the metabolic output and profile of the microbiome.